10x Genomics Balance Sheet Health
Financial Health criteria checks 6/6
10x Genomics has a total shareholder equity of $722.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $937.8M and $215.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$398.16m |
| Equity | US$722.80m |
| Total liabilities | US$214.99m |
| Total assets | US$937.79m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0A88's short term assets ($593.9M) exceed its short term liabilities ($121.2M).
Long Term Liabilities: 0A88's short term assets ($593.9M) exceed its long term liabilities ($93.8M).
Debt to Equity History and Analysis
Debt Level: 0A88 is debt free.
Reducing Debt: 0A88 has no debt compared to 5 years ago when its debt to equity ratio was 7%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 0A88 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 0A88 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 1% per year.